Electrical acupoint stimulation plus three anti-nausea drugs to prevent post-op nausea in high-risk women
Official title: Transcutaneous Electrical Acupoint Stimulation Combined With Triple Antiemetic Drugs for Postoperative Nausea and Vomiting in High-Risk Patients: A Multicenter Randomized Controlled Trial
Run by Zhejiang University · NCT07480785 · Data updated 2026-11-12
This trial will test whether adding wearable electrical acupoint stimulation to three anti-nausea drugs reduces postoperative nausea and vomiting in high-risk adult women having elective laparoscopic surgery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | Women only |
| Enrollment | 780 (estimated) |
| Sponsor | Zhejiang University Academic / other |
| Locations | 1 site (Hangzhou, Zhejiang) |
| Status | Recruiting |
| Started | January 16, 2026 |
| Main results expected | October 31, 2027 |
| Study ends | October 31, 2027 |
| Registry record updated | March 18, 2026 |
| Trial ID | NCT07480785 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adult women (18–65 years) at high risk for PONV (Apfel score ≥3) scheduled for elective laparoscopic surgery who meet ASA I–III criteria are ideal candidates.
✕Probably not a fit
Patients who are current smokers, pregnant or breastfeeding, have implanted cardiac devices, severe hepatic/renal impairment, or other listed exclusions are unlikely to be eligible or to receive benefit from this approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, blinded interventional study will enroll 780 women aged 18–65 with high PONV risk (Apfel score ≥3) undergoing elective laparoscopic procedures. All participants receive a standardized triple antiemetic regimen (dexamethasone, palonosetron, droperidol) and are randomized to active transcutaneous electrical acupoint stimulation (TEAS at P6 and L14) or a sham stimulation control. Active TEAS is applied from 30 minutes before induction and maintained through recovery, while sham stimulation uses minimal perceptible current for 1 minute. Outcomes include incidence of postoperative nausea and vomiting and need for rescue antiemetics, with blinded data collection by trained anesthesiologists.
Why it matters
Potential benefit: If successful, the addition of TEAS could meaningfully reduce post-surgery nausea and vomiting and lower the need for rescue medications.
How similar studies have gone: Prior smaller studies of P6 acupoint stimulation have shown reductions in PONV when combined with antiemetics, but results have been mixed and adequately powered randomized data remain limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women scheduled for laparoscopic surgery ； * Aged 18-65 years； * ASA Class I-III； * Apfel score ≥ 3 (female sex, non-smoker, history of PONV and/or motion sickness). Exclusion Criteria: * Patients with a history of allergy to the investigational drug or contraindications； * Long-QT syndrome ； * Pregnancy, lactation, or menstruation ； * Current smoker； * Nausea/vomiting or use of antiemetics, opioids, or systemic corticosteroids within 24 h before surgery； * Requirement for post-operative sedation and mechanical ventilation ； * Severe renal or hepatic impairment ； * Psychiatric or neurological disorder ； * Vertebrobasilar insufficiency； * Vestibular disease； * Language or communication barrier ； * Skin lesion or infection at the acupoint stimulation site ； * Upper-limb nerve injury ； * Implanted cardiac pacemaker or defibrillator ； * Participation in another clinical trial within the past 4 weeks.
Where it's running
-
The First Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, China Recruiting
Study contacts
- Study coordinator: Diansan Su, PhD
- Email: diansansu@yahoo.com
- Phone: +8618616514088
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Stellate ganglion block and dexmedetomidine for better sleep after gynecologic laparoscopy
The study tests whether giving a preoperative stellate ganglion block plus intraoperative dexmedetomidine improves sleep after laparoscopic gynecologic surgery in women.
-
EGCG and Vitamin D3 to Help Prevent Fibroid Recurrence After Fibroid Removal
This trial tests whether daily EGCG and vitamin D3 after fibroid surgery can reduce the chances of fibroids coming back in premenopausal women.
-
Predicting pain relief after gallbladder removal
This will test a prediction score to see if people with uncomplicated gallstones scheduled for laparoscopic gallbladder removal will be pain-free three months after surgery.
-
Robotic versus laparoscopic gallbladder removal for benign gallbladder disease
This trial will test whether robotic gallbladder removal is as safe as standard laparoscopic surgery for adults who need their gallbladder removed for benign disease.
-
Evaluation of a new robotic surgical system for major gastrointestinal and urologic surgeries
This study is testing a new robotic surgery system to see if it can safely and effectively help patients with major gastrointestinal and urologic conditions like colorectal and prostate cancer.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.